What Is 2-methylacetoacetyl-CoA thiolase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 2-methylacetoacetyl-CoA thiolase is a mitochondrial enzyme encoded by the ACAT1 gene in humans, crucial for ketone body metabolism and isoleucine catabolism. Deficiency in this enzyme leads to 2-methylacetoacetyl-CoA thiolase deficiency (MAT deficiency), a rare autosomal recessive disorder first described in 1981.

Key Facts

The ACAT1 gene, which encodes 2-methylacetoacetyl-CoA thiolase, is located on chromosome 11q22.3
MAT deficiency was first clinically described in 1981 in a Japanese patient presenting with metabolic acidosis
The enzyme catalyzes the cleavage of 2-methylacetoacetyl-CoA into acetyl-CoA and propionyl-CoA
Over 40 mutations in the ACAT1 gene have been linked to MAT deficiency as of 2023
The enzyme has a molecular weight of approximately 42 kDa and functions as a homodimer

Overview

2-methylacetoacetyl-CoA thiolase, also known as mitochondrial acetoacetyl-CoA thiolase or T2 enzyme, is a key enzyme in the catabolism of isoleucine and ketone body utilization. It plays a critical role in mitochondrial metabolism by catalyzing the thiolytic cleavage of specific CoA esters, enabling energy production during fasting or high-fat metabolism.

Encoded by the ACAT1 gene, this enzyme is expressed primarily in liver and kidney mitochondria. Its deficiency leads to a rare inborn error of metabolism affecting organic acid metabolism, typically presenting in infancy with life-threatening ketoacidosis and neurological symptoms.

Enzyme function: Catalyzes the reversible cleavage of 2-methylacetoacetyl-CoA into acetyl-CoA and propionyl-CoA, a vital step in isoleucine degradation.
Gene location: The ACAT1 gene is located on human chromosome 11q22.3 and spans approximately 22 kilobases with 10 exons.
Protein structure: Functions as a homodimer with each subunit weighing about 42 kDa, requiring coenzyme A and magnesium ions for activity.
Metabolic pathway: Participates in both ketone body oxidation and branched-chain amino acid catabolism, linking amino acid and lipid metabolism.
Clinical relevance: Deficiency causes 2-methylacetoacetyl-CoA thiolase deficiency (MAT deficiency), a condition with fewer than 100 cases reported worldwide.

How It Works

The enzyme operates through a thiolysis reaction mechanism involving nucleophilic attack on the substrate's carbonyl carbon, facilitated by active-site cysteine residues. This process allows the breakdown of 2-methylacetoacetyl-CoA into two acetyl-CoA molecules or related intermediates depending on the metabolic context.

Substrate specificity: Acts specifically on 2-methylacetoacetyl-CoA and acetoacetyl-CoA, distinguishing it from other thiolases involved in fatty acid oxidation.
Catalytic mechanism: Uses a cysteine residue (Cys90) to form a covalent intermediate, followed by nucleophilic attack by CoA-SH to release products.
pH optimum: Exhibits maximal activity at pH 8.0 in mitochondrial matrix conditions, reflecting its physiological environment.
Co-factor requirement: Requires free coenzyme A and Mg²⁺ ions for optimal enzymatic activity and structural stability.
Reaction reversibility: The reaction is reversible, allowing the enzyme to participate in both catabolic and anabolic pathways under different metabolic states.
Gene expression:ACAT1 is transcriptionally regulated by PPAR-alpha, linking its expression to fasting and lipid metabolism signals.

Comparison at a Glance

Below is a comparison of 2-methylacetoacetyl-CoA thiolase with other related mitochondrial thiolases based on substrate specificity, tissue distribution, and clinical implications.

Enzyme	Gene	Primary Substrate	Tissue Expression	Clinical Disorder
2-methylacetoacetyl-CoA thiolase	ACAT1	2-methylacetoacetyl-CoA	Liver, kidney	MAT deficiency
Succinyl-CoA:3-ketoacid CoA transferase	OXCT1	Acetoacetate	Widespread	SCOT deficiency
Short-chain thiolase	ACAA2	Acetoacetyl-CoA	Liver, muscle	None well-defined
Trifunctional protein α-subunit	HADHA	Fatty acyl-CoA	Heart, liver	TFP deficiency
Propionyl-CoA carboxylase	PCCA/PCCB	Propionyl-CoA	Liver, kidney	Propionic acidemia

This table highlights how 2-methylacetoacetyl-CoA thiolase is specialized for branched-chain amino acid metabolism, unlike other thiolases involved in fatty acid or ketone body processing. Its restricted expression and unique substrate profile make it a critical diagnostic target in organic acidemias.

Why It Matters

Understanding this enzyme's function is essential for diagnosing and managing rare metabolic disorders, particularly in neonatal screening and emergency metabolic care. Its role in energy metabolism during fasting makes it a key player in maintaining metabolic homeostasis in infants and children.

Diagnostic marker: Elevated 2-methyl-3-hydroxybutyric acid and tiglylglycine in urine organic acid analysis are hallmark signs of MAT deficiency.
Neonatal screening: Some regions include C5-OH acylcarnitine in tandem mass spectrometry panels to detect MAT deficiency early.
Therapeutic approach: Treatment involves avoiding fasting, using low-protein diets, and administering glucose during illness to prevent metabolic crises.
Genetic counseling: As an autosomal recessive disorder, families with one affected child have a 25% recurrence risk.
Prognosis: Early diagnosis and management improve outcomes, though neurological impairment can occur after severe metabolic episodes.
Research significance: Studying ACAT1 mutations helps elucidate mitochondrial enzyme regulation and informs gene therapy development.

Given its pivotal role in metabolism, continued research into 2-methylacetoacetyl-CoA thiolase enhances our ability to treat rare diseases and understand fundamental biochemical processes.